Found 8 results
Author Title [ Type(Desc)] Year
Filters: Author is Chen, WH  [Clear All Filters]
Journal Article
L. A. Jackson, Chen, W. H., Stapleton, J. T., Dekker, C. L., Wald, A., Brady, R. C., Edupuganti, S., Winokur, P., Mulligan, M. J., Keyserling, H. L., Kotloff, K. L., Rouphael, N., Noah, D. L., Hill, H., and Wolff, M. C., “Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons”, J Infect Dis, vol. 206, pp. 811-820, 2012.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., Creech, C. B., Hill, H., and Bellamy, A. R., “Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial”, JAMA, vol. 312, pp. 1420-1428, 2014.
D. Bernstein, Atmar, R. L., Lyon, G. M., Treanor, J., Chen, W. H., Jiang, X., Vinje, J., Gregoricus, N., Jr, R. W. Frenck, Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., “Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults”, J Infect Dis, vol. jiu497 [pi, 2014.
R. L. Atmar, Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., and Mendelman, P. M., “Norovirus Vaccine Against Experimental Human Norwalk Virus Illness”, N Engl J Med, vol. 365, pp. 2178-2187, 2011.
J. J. Treanor, Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., “A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate-Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults”, J Infect Dis, vol. pii: jiu33, 2014.
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., Kotloff, K. L., Chua, J. V., Hutter, J., Stephens, I., Stapleton, J., Meier, J., Callahan, S. T., Creech, C. B., Halasa, N. B., Johnston, C., Dolor, R. J., Schmader, K. E., Woods, C. W., and Hill, H., “Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009”, Vaccine, vol. 13, pp. 4240-4248, 2012.
P. L. Winokur, Patel, S. M., Brady, R., Chen, W. H., El-Kamary, S. S., Edwards, K., Creech, C. B., Frey, S., Keitel, W. A., Belshe, R., Walter, E., Bellamy, A., Hill, H., and Group, T. V. T. E. U. - H. 3Nv, “Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine”, J Infect Dis, vol. 212, pp. 525-530, 2015.
R. C. Brady, Treanor, J. J., Atmar, R. L., Keitel, W. A., Edelman, R., Chen, W. H., Winokur, P., Belshe, R., Graham, I. L., Noah, D. L., Guo, K., and Hill, H., “Safety and Immunogenicity of a Subvirion Inactivated Influenza a/H5N1 Vaccine With or Without Aluminum Hydroxide Among Healthy Elderly Adults”, Vaccine, vol. 27, pp. 5091-5095, 2009.